Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants

The ongoing pandemic of COVID-19, caused by SARS-CoV-2, has severely impacted the global public health and socio-economic stability, calling for effective vaccines and therapeutics. In this study, we continued our efforts to develop more efficient SARS-CoV-2 fusion inhibitors and achieved significan...

Descripció completa

Dades bibliogràfiques

Autors principals:	Danwei Yu, Yuanmei Zhu, Tao Jiao, Tong Wu, Xia Xiao, Bo Qin, Huihui Chong, Xiaobo Lei, Lili Ren, Sheng Cui, Jianwei Wang, Yuxian He
Format:	Artigo
Idioma:	Inglês
Publicat:	Taylor & Francis Group 2021-01-01
Col·lecció:	Emerging Microbes and Infections
Matèries:	SARS-CoV-2 spike protein membrane fusion fusion inhibitor lipopeptide
Accés en línia:	https://www.tandfonline.com/doi/10.1080/22221751.2021.1937329
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!